Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.
Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has added a new section titled 'Results Submitted' that includes contact details for inquiries about joining the study and information on its location, while removing the previous section on 'No Results Posted'.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference5%
- Check36 days agoChange DetectedSeveral links related to cancer information and resources have been removed, including those from MedlinePlus and Rare Diseases, which may impact access to important health information.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added related to uterine cancer and various sarcomas, including links to MedlinePlus and NIH rare disease information.SummaryDifference7%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.